AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 7981560 — intervention group
Group type: EXPERIMENTAL
Intervention: Zinc supplementation (10 mg/day)
Number of subjects: 79
Study 7981560 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 79
Study 30442080 — intervention group
Group type: EXPERIMENTAL
Intervention: Trandolapril (ACE inhibitor)
Number of subjects: 2512
Study 26363481 — intervention group
Group type: EXPERIMENTAL
Intervention: Transvaginal cervical length (TVCL) assessment and digital exams monthly from 16‐28 weeks with standard management algorithm for activity restriction and cerclage
Number of subjects: 125
Study 26363481 — intervention group
Group type: COMPARATOR
Intervention: Monthly digital cervical examinations without routine TVCL ultrasound
Number of subjects: 125
Study 26363481 — intervention group
Group type: EXPERIMENTAL
Intervention: Transvaginal cervical length (TVCL) assessment
Number of subjects: 125
Study 26363481 — intervention group
Group type: COMPARATOR
Intervention: Control group (no routine TVCL)
Number of subjects: 125
Study 24892203 — intervention group
Group type: EXPERIMENTAL
Intervention: Audio tempo at 125% of baseline cadence
Number of subjects: 36
Study 24892203 — intervention group
Group type: EXPERIMENTAL
Intervention: Audio tempo at 75% and 100% of baseline cadence
Number of subjects: 36
Study 24892203 — intervention group
Group type: EXPERIMENTAL
Intervention: Optic flow (50% and 100% of preferred walking speed)
Number of subjects: 36
Study 22193628 — intervention group
Group type: EXPERIMENTAL
Intervention: Novel conditionally replicating adenoviral vector (CRAd) expressing IL-24 and arresten
Number of subjects: 0
Study 22193628 — intervention group
Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 0
Study 18332150 — intervention group
Group type: EXPERIMENTAL
Intervention: Culturally appropriate stroke education program, divided into four 50-minute classes each year during sixth, seventh, and eighth grades.
Number of subjects: 0
Study 18332150 — intervention group
Group type: COMPARATOR
Intervention: Control group (not specified in detail).
Number of subjects: 0
Study 19738135 — intervention group
Group type: EXPERIMENTAL
Intervention: Metabolic syndrome (MetS)
Number of subjects: 27111
Study 19738135 — intervention group
Group type: EXPERIMENTAL
Intervention: Metabolic syndrome (MetS) after multivariable adjustment
Number of subjects: 27111
Study 19738135 — intervention group
Group type: EXPERIMENTAL
Intervention: Each additional MetS-defining trait
Number of subjects: 27111
Study 19738135 — intervention group
Group type: COMPARATOR
Intervention: High-sensitivity C-reactive protein
Number of subjects: 27111
Study 19738135 — intervention group
Group type: COMPARATOR
Intervention: Soluble intercellular adhesion molecule-1
Number of subjects: 27111
Study 19738135 — intervention group
Group type: EXPERIMENTAL
Intervention: Metabolic syndrome (MetS) with inflammation markers included in multivariable models
Number of subjects: 27111
Study 16859225 — intervention group
Group type: EXPERIMENTAL
Intervention: Sterile saline
Number of subjects: 89
Study 16859225 — intervention group
Group type: EXPERIMENTAL
Intervention: Acetic acid
Number of subjects: 89
Study 16859225 — intervention group
Group type: EXPERIMENTAL
Intervention: Neomycin-polymyxin solution
Number of subjects: 89
Study 12590375 — intervention group
Group type: EXPERIMENTAL
Intervention: Clonidine 0.15 mg/day
Number of subjects: 32
Study 12590375 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 32
Study 10867600 — intervention group
Group type: EXPERIMENTAL
Intervention: Respimat delivering 50/20, 25/20 or 25/10 microg F/I per puff
Number of subjects: 43
Study 10867600 — intervention group
Group type: COMPARATOR
Intervention: MDI delivering 50/20 microg F/I per puff
Number of subjects: 43
Study 9355894 — intervention group
Group type: EXPERIMENTAL
Intervention: Mibefradil 100 mg
Number of subjects: 309
Study 9355894 — intervention group
Group type: EXPERIMENTAL
Intervention: Mibefradil 150 mg
Number of subjects: 309
Study 9355894 — intervention group
Group type: EXPERIMENTAL
Intervention: Amlodipine 10 mg
Number of subjects: 309
Study 8408529 — intervention group
Group type: EXPERIMENTAL
Intervention: RU486 (600 mg)
Number of subjects: 0
Study 8408529 — intervention group
Group type: EXPERIMENTAL
Intervention: RU486 (3 x 25 mg)
Number of subjects: 0
Study 8408529 — intervention group
Group type: EXPERIMENTAL
Intervention: RU486 (25 mg)
Number of subjects: 0
Study 8408529 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 2880597 — intervention group
Group type: EXPERIMENTAL
Intervention: Low alcohol content beer only
Number of subjects: 46
Study 29995949 — intervention group
Group type: EXPERIMENTAL
Intervention: Exclusively breastfed until age 4‐5 months
Number of subjects: 236
Study 29995949 — intervention group
Group type: EXPERIMENTAL
Intervention: Exclusively breastfed until age 6‐10 months
Number of subjects: 236
Study 29995949 — intervention group
Group type: COMPARATOR
Intervention: Exclusively breastfed for 0‐1 months
Number of subjects: 236
Study 27325848 — intervention group
Group type: EXPERIMENTAL
Intervention: Telephone genetic counseling
Number of subjects: 988
Study 25046068 — intervention group
Group type: EXPERIMENTAL
Intervention: Nasal packing and transseptal suture technique (Group 1, n=16)
Number of subjects: 38
Study 25046068 — intervention group
Group type: COMPARATOR
Intervention: Transseptal suture technique (Group 2, n=22)
Number of subjects: 38
Study 22469880 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined exercise program (6 months)
Number of subjects: 41
Study 22469880 — intervention group
Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 41
Study 20439295 — intervention group
Group type: EXPERIMENTAL
Intervention: Rituximab plus methotrexate (MTX)
Number of subjects: 468
Study 20439295 — intervention group
Group type: COMPARATOR
Intervention: Placebo plus methotrexate (MTX)
Number of subjects: 468
Study 18633045 — intervention group
Group type: EXPERIMENTAL
Intervention: CEA regional
Number of subjects: 60
Study 18633045 — intervention group
Group type: COMPARATOR
Intervention: Control group (sedation)
Number of subjects: 60
Study 15722780 — intervention group
Group type: EXPERIMENTAL
Intervention: Drug therapies for complex regional pain syndrome
Number of subjects: 0
Study 15722780 — intervention group
Group type: EXPERIMENTAL
Intervention: Pharmacotherapy coupled with functional restoration and interdisciplinary approach
Number of subjects: 0
Study 12229131 — intervention group
Group type: COMPARATOR
Intervention: Morphine (IV PCA) alone (2 mg bolus, 10-minute lock-out interval, 10 mg/hour limit for 48 hours)
Number of subjects: 20
Study 10102019 — intervention group
Group type: EXPERIMENTAL
Intervention: Conventional cranial irradiation (CRT) regimen (L874A and I874A) - 18-Gy CRT plus 3 doses of intrathecal (i.t.) MTX
Number of subjects: 572
Study 10102019 — intervention group
Group type: COMPARATOR
Intervention: High-dose methotrexate (HDMTX) regimen without CRT (L874B and I874B) - 3 courses of HDMTX at 2 g/m2 plus 13 doses of ITMTX or 4 courses of HDMTX at 4.5 g/m2 plus 1 dose of ITMTX
Number of subjects: 572
Study 10102019 — intervention group
Group type: EXPERIMENTAL
Intervention: Conventional cranial irradiation (CRT) regimen (I874A)
Number of subjects: 572
Study 10102019 — intervention group
Group type: COMPARATOR
Intervention: High-dose methotrexate (HDMTX) regimen without CRT (I874B)
Number of subjects: 572
Study 10102019 — intervention group
Group type: EXPERIMENTAL
Intervention: Intensive systemic chemotherapy with extended i.t. injections of MTX plus cytarabine
Number of subjects: 572
Study 10102019 — intervention group
Group type: EXPERIMENTAL
Intervention: Cranial irradiation (18-Gy or 24-Gy) with intensive systemic chemotherapy
Number of subjects: 572
Study 7770400 — intervention group
Group type: EXPERIMENTAL
Intervention: Omeprazole (20 mg)
Number of subjects: 545
Study 7770400 — intervention group
Group type: COMPARATOR
Intervention: Ranitidine (300 mg)
Number of subjects: 545
Study 2265371 — intervention group
Group type: EXPERIMENTAL
Intervention: HPP 3 x 300 mg po, days 1-5, 5-FU 800 mg/m2 push iv, days 3-5 and DDP 50 mg/m2 d6
Number of subjects: 104
Study 2265371 — intervention group
Group type: COMPARATOR
Intervention: 5-FU alone 500 mg/m2 push iv days 1-5
Number of subjects: 104
Study 2265371 — intervention group
Group type: EXPERIMENTAL
Intervention: HPP-5-FU-DDP
Number of subjects: 104
Study 2265371 — intervention group
Group type: COMPARATOR
Intervention: 5-FU
Number of subjects: 104
Study 7004247 — intervention group
Group type: EXPERIMENTAL
Intervention: Oxatomide
Number of subjects: 40
Study 7004247 — intervention group
Group type: COMPARATOR
Intervention: Cinnarizine in combination with phenylpropanolamine
Number of subjects: 40
Study 7004247 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 40
Study 31567951 — intervention group
Group type: EXPERIMENTAL
Intervention: PNF-treated group (respiratory stimulation through Proprioceptive Neuromuscular Facilitation)
Number of subjects: 60
Study 31567951 — intervention group
Group type: COMPARATOR
Intervention: PNF-untreated group (positioning)
Number of subjects: 60
Study 28248418 — intervention group
Group type: EXPERIMENTAL
Intervention: Customized behavioral urinary incontinence treatments combined with physical activity (150 minutes of weekly walking and twice weekly strength training classes)
Number of subjects: 42
Study 28248418 — intervention group
Group type: EXPERIMENTAL
Intervention: Customized behavioral urinary incontinence treatments combined with physical activity
Number of subjects: 42
Study 28248418 — intervention group
Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 42
Study 25271779 — intervention group
Group type: EXPERIMENTAL
Intervention: Group cognitive-behavioral therapy (22 sessions)
Number of subjects: 44
Study 25271779 — intervention group
Group type: COMPARATOR
Intervention: Group supportive therapy (control, 22 sessions)
Number of subjects: 44
Study 23357523 — intervention group
Group type: EXPERIMENTAL
Intervention: General anaesthesia plus epidural (GAE)
Number of subjects: 226
Study 21733037 — intervention group
Group type: EXPERIMENTAL
Intervention: Aerobic exercise at an intensity of 50‐65% of maximum heart rate for 60 min, three times a week for 16 weeks
Number of subjects: 64
Study 21733037 — intervention group
Group type: COMPARATOR
Intervention: Usual physical activity
Number of subjects: 64
Study 19731229 — intervention group
Group type: EXPERIMENTAL
Intervention: Seldinger technique
Number of subjects: 152
Study 19731229 — intervention group
Group type: COMPARATOR
Intervention: venous cutdown
Number of subjects: 152
Study 19731229 — intervention group
Group type: EXPERIMENTAL
Intervention: both techniques
Number of subjects: 152
Study 17596103 — intervention group
Group type: EXPERIMENTAL
Intervention: Vildagliptin 25 mg
Number of subjects: 13
Study 17596103 — intervention group
Group type: EXPERIMENTAL
Intervention: Vildagliptin 100 mg
Number of subjects: 13
Study 17596103 — intervention group
Group type: EXPERIMENTAL
Intervention: Vildagliptin 10 mg
Number of subjects: 13
Study 17596103 — intervention group
Group type: EXPERIMENTAL
Intervention: Vildagliptin 25 mg and 100 mg
Number of subjects: 13
Study 17596103 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 13
Study 14872477 — intervention group
Group type: EXPERIMENTAL
Intervention: Escalating doses of IM methotrexate up to 45 mg/week
Number of subjects: 64
Study 14872477 — intervention group
Group type: COMPARATOR
Intervention: 15 mg/week IM methotrexate with monthly placebo escalation
Number of subjects: 64
Study 11163032 — intervention group
Group type: EXPERIMENTAL
Intervention: Allopurinol (administered with pre-medication)
Number of subjects: 29
Study 11163032 — intervention group
Group type: COMPARATOR
Intervention: Standard care (without allopurinol)
Number of subjects: 29
Study 9250753 — intervention group
Group type: EXPERIMENTAL
Intervention: Reinfusion of unwashed blood salvaged after operation
Number of subjects: 70
Study 9250753 — intervention group
Group type: COMPARATOR
Intervention: Homologous bank blood
Number of subjects: 70
Study 7684865 — intervention group
Group type: EXPERIMENTAL
Intervention: Strontium-89 (400 MBq)
Number of subjects: 126
Study 3430248 — intervention group
Group type: COMPARATOR
Intervention: WHO ORS
Number of subjects: 93
Study 3430248 — intervention group
Group type: EXPERIMENTAL
Intervention: Pop rice ORS
Number of subjects: 93
Study 3430248 — intervention group
Group type: EXPERIMENTAL
Intervention: Mung bean ORS
Number of subjects: 93
Study 31180297 — intervention group
Group type: EXPERIMENTAL
Intervention: Epoetin beta treatment to a hemoglobin target level of 11.5 to 13.5 g/dL
Number of subjects: 55
Study 31180297 — intervention group
Group type: EXPERIMENTAL
Intervention: Epoetin beta treatment
Number of subjects: 55
Study 31180297 — intervention group
Group type: COMPARATOR
Intervention: No treatment
Number of subjects: 55
Study 30026086 — intervention group
Group type: EXPERIMENTAL
Intervention: Pressure Support Ventilation (PSV)
Number of subjects: 8
Study 30026086 — intervention group
Group type: EXPERIMENTAL
Intervention: Neurally Adjusted Ventilatory Assist (NAVA)
Number of subjects: 8
Study 28069598 — intervention group
Group type: EXPERIMENTAL
Intervention: Interactive Voice Response brief intervention (IVR‐BI)
Number of subjects: 1855
Study 28069598 — intervention group
Group type: COMPARATOR
Intervention: No IVR‐BI control
Number of subjects: 1855
Study 28069598 — intervention group
Group type: EXPERIMENTAL
Intervention: Both conditions (IVR‐BI and No IVR‐BI)
Number of subjects: 1855
Study 25446490 — intervention group
Group type: EXPERIMENTAL
Intervention: Single-incision laparoscopic cholecystectomy (SILC)
Number of subjects: 100
Study 25446490 — intervention group
Group type: COMPARATOR
Intervention: Conventional laparoscopic cholecystectomy (LC)
Number of subjects: 100
Study 22684155 — intervention group
Group type: EXPERIMENTAL
Intervention: Blended learning group (additional online access to the PENSKE Baby Check Learning Module)
Number of subjects: 81
Study 22684155 — intervention group
Group type: COMPARATOR
Intervention: Control group (standard neonatology teaching programme)
Number of subjects: 81
Study 22070129 — intervention group
Group type: EXPERIMENTAL
Intervention: P‐R drink (n = 20)
Number of subjects: 39
Study 22070129 — intervention group
Group type: COMPARATOR
Intervention: Placebo (n = 19)
Number of subjects: 39
Study 19523092 — intervention group
Group type: EXPERIMENTAL
Intervention: Intra-observer measurement
Number of subjects: 70
Study 19523092 — intervention group
Group type: EXPERIMENTAL
Intervention: Inter-observer measurement
Number of subjects: 70
Study 16681436 — intervention group
Group type: EXPERIMENTAL
Intervention: Adrenocorticotrophic hormone (ACTH)(1‐24) 1 mg i.m. daily for 4 days
Number of subjects: 30
Study 16681436 — intervention group
Group type: EXPERIMENTAL
Intervention: Cortisol 50 mg i.m. t.i.d. for 4 days
Number of subjects: 30
Study 16681436 — intervention group
Group type: COMPARATOR
Intervention: Control group (observed for 4 days)
Number of subjects: 30
Study 15530678 — intervention group
Group type: EXPERIMENTAL
Intervention: dTpa
Number of subjects: 0
Study 15530678 — intervention group
Group type: COMPARATOR
Intervention: DTPa
Number of subjects: 0
Study 11177066 — intervention group
Group type: EXPERIMENTAL
Intervention: Individualized safer sex intervention (videotape and intervention session)
Number of subjects: 123
Study 11177066 — intervention group
Group type: COMPARATOR
Intervention: Standard STD education (control)
Number of subjects: 123
Study 9771317 — intervention group
Group type: EXPERIMENTAL
Intervention: Extubation while awake
Number of subjects: 84
Study 9771317 — intervention group
Group type: COMPARATOR
Intervention: Extubation while sedated (propofol 1‐3 mg kg‐1 h‐1)
Number of subjects: 84
Study 9771317 — intervention group
Group type: COMPARATOR
Intervention: Extubation while sedated
Number of subjects: 84
Study 7827234 — intervention group
Group type: EXPERIMENTAL
Intervention: 1-step procedure for fixture installation and abutment connection
Number of subjects: 11
Study 7827234 — intervention group
Group type: COMPARATOR
Intervention: 2-step procedure for fixture installation and abutment connection
Number of subjects: 11
Study 3063797 — intervention group
Group type: EXPERIMENTAL
Intervention: Captopril 50 mg sublingually
Number of subjects: 22
Study 3063797 — intervention group
Group type: COMPARATOR
Intervention: Nifedipine 10 mg sublingually
Number of subjects: 22
Study 30958836 — intervention group
Group type: EXPERIMENTAL
Intervention: Video-based Apple Keynote presentation
Number of subjects: 45
Study 30958836 — intervention group
Group type: COMPARATOR
Intervention: Serious game in a 3D learning environment
Number of subjects: 45
Study 30958836 — intervention group
Group type: EXPERIMENTAL
Intervention: Serious game
Number of subjects: 45
Study 28981820 — intervention group
Group type: EXPERIMENTAL
Intervention: 8% cooked starch
Number of subjects: 5
Study 28981820 — intervention group
Group type: EXPERIMENTAL
Intervention: 8% raw starch
Number of subjects: 5
Study 28981820 — intervention group
Group type: EXPERIMENTAL
Intervention: Salivary α-amylase activity
Number of subjects: 5
Study 28981820 — intervention group
Group type: EXPERIMENTAL
Intervention: Effective α-amylase activity
Number of subjects: 5
Study 28981820 — intervention group
Group type: EXPERIMENTAL
Intervention: Carbohydrate consumption score
Number of subjects: 5
Study 25349295 — intervention group
Group type: EXPERIMENTAL
Intervention: FOLFOX (infusional fluorouracil, leucovorin, and oxaliplatin)
Number of subjects: 1002
Study 24138652 — intervention group
Group type: EXPERIMENTAL
Intervention: CTCA followed by CCA
Number of subjects: 0
Study 24138652 — intervention group
Group type: COMPARATOR
Intervention: CCA alone
Number of subjects: 0
Study 21311184 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral mycophenolate mofetil (MMF) 1.0 g/day (1.5 g/day for patients >70 kg)
Number of subjects: 41
Study 21311184 — intervention group
Group type: COMPARATOR
Intervention: Intravenous cyclophosphamide (IVC) 1.0 g per pulse (0.8 g for patients <50 kg)
Number of subjects: 41
Study 19852602 — intervention group
Group type: EXPERIMENTAL
Intervention: Intrusive force applied to test teeth
Number of subjects: 21
Study 19852602 — intervention group
Group type: COMPARATOR
Intervention: Control teeth (contralateral premolar)
Number of subjects: 21
Study 16722277 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.75% ropivacaine
Number of subjects: 72
Study 16722277 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.5% ropivacaine
Number of subjects: 72
Study 16722277 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.375% ropivacaine
Number of subjects: 72
Study 16722277 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.25% ropivacaine
Number of subjects: 72
Study 14707325 — intervention group
Group type: EXPERIMENTAL
Intervention: Amantadine (100 mg)
Number of subjects: 40
Study 14707325 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 40
Study 11563430 — intervention group
Group type: EXPERIMENTAL
Intervention: Wearing disposable soft tinted contact lenses (Optima Colors lenses by Bausch & Lomb)
Number of subjects: 16
Study 11563430 — intervention group
Group type: COMPARATOR
Intervention: Not wearing the disposable soft tinted contact lenses
Number of subjects: 16
Study 9143447 — intervention group
Group type: EXPERIMENTAL
Intervention: Kinetic gratings under passive viewing conditions
Number of subjects: 0
Study 9143447 — intervention group
Group type: COMPARATOR
Intervention: Uniform motion
Number of subjects: 0
Study 9143447 — intervention group
Group type: COMPARATOR
Intervention: Luminance defined gratings
Number of subjects: 0
Study 8201490 — intervention group
Group type: EXPERIMENTAL
Intervention: terfenadine, 60 mg
Number of subjects: 15
Study 8201490 — intervention group
Group type: EXPERIMENTAL
Intervention: chlorpheniramine, 4 mg
Number of subjects: 15
Study 8201490 — intervention group
Group type: COMPARATOR
Intervention: placebo
Number of subjects: 15
Study 3276299 — intervention group
Group type: EXPERIMENTAL
Intervention: Controlled-release carbidopa-levodopa (CR-2 or CR-3)
Number of subjects: 20
Study 3276299 — intervention group
Group type: COMPARATOR
Intervention: Standard carbidopa-levodopa (Sinemet, 25 mg/100 mg)
Number of subjects: 20
Study 30320138 — intervention group
Group type: EXPERIMENTAL
Intervention: Contact force information visible (n=35)
Number of subjects: 72
Study 30320138 — intervention group
Group type: COMPARATOR
Intervention: Contact force information blinded (n=37)
Number of subjects: 72
Study 30320138 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 72
Study 29178684 — intervention group
Group type: EXPERIMENTAL
Intervention: Exercise intervention (2 or 3 times each week, 30 minutes per session at 65%-85% Vo2max for 12 weeks)
Number of subjects: 12
Study 26289425 — intervention group
Group type: EXPERIMENTAL
Intervention: BAcPAc (Behavioural Activation plus physical activity promotion)
Number of subjects: 60
Study 26289425 — intervention group
Group type: COMPARATOR
Intervention: BA (Behavioural Activation)
Number of subjects: 60
Study 23931259 — intervention group
Group type: EXPERIMENTAL
Intervention: Plastic curets + cotton pellets + sterile saline (CPS)
Number of subjects: 17
Study 23931259 — intervention group
Group type: COMPARATOR
Intervention: Er:YAG laser (ERL)
Number of subjects: 17
Study 21167330 — intervention group
Group type: EXPERIMENTAL
Intervention: Multi-component physical activity intervention including daily physical education with at least 10 min of jumping or strength training exercises of various intensities.
Number of subjects: 502
Study 21167330 — intervention group
Group type: COMPARATOR
Intervention: Control group (no specific intervention details provided).
Number of subjects: 502
Study 18923235 — intervention group
Group type: EXPERIMENTAL
Intervention: Prasugrel
Number of subjects: 0
Study 18923235 — intervention group
Group type: COMPARATOR
Intervention: Clopidogrel
Number of subjects: 0
Study 21927893 — intervention group
Group type: EXPERIMENTAL
Intervention: Lifestyle intervention for 9 months
Number of subjects: 28
Study 21927893 — intervention group
Group type: EXPERIMENTAL
Intervention: Lifestyle intervention for 2 years
Number of subjects: 28
Study 15818098 — intervention group
Group type: EXPERIMENTAL
Intervention: Active impedance threshold device
Number of subjects: 230
Study 15818098 — intervention group
Group type: COMPARATOR
Intervention: Sham impedance threshold device
Number of subjects: 230
Study 14645173 — intervention group
Group type: EXPERIMENTAL
Intervention: Follicular fluid meiosis-activating sterol (FF-MAS)
Number of subjects: 144
Study 14645173 — intervention group
Group type: COMPARATOR
Intervention: Control solutions
Number of subjects: 144
Study 14645173 — intervention group
Group type: EXPERIMENTAL
Intervention: Criteria for good embryo quality
Number of subjects: 144
Study 10594624 — intervention group
Group type: EXPERIMENTAL
Intervention: Foam and plastic tapes
Number of subjects: 0
Study 10594624 — intervention group
Group type: EXPERIMENTAL
Intervention: Application on the forearm
Number of subjects: 0
Study 10594624 — intervention group
Group type: EXPERIMENTAL
Intervention: Adding a gauze roll to the dressing
Number of subjects: 0
Study 8576672 — intervention group
Group type: COMPARATOR
Intervention: Balanced technique anesthesia (Group 1)
Number of subjects: 47